Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
about
Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diary.Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST).A descriptive review on methods to prioritize outcomes in a health care context.The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.Health state utilities associated with attributes of treatments for hepatitis C.Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.Physician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trials.The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals.Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence.Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion.Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completion.Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.Patient preferences for a polypill for the prevention of cardiovascular diseases.
P2860
Q30870323-592FA66B-EED3-4BCB-AB77-BE2703BBC308Q33651573-D5F4C562-D6C7-408D-A562-8B9F62D51FEFQ34718400-85C3BC32-6752-4532-B251-B8EBDE6D41FCQ35117875-26BCCFAC-7C64-4F6E-BB31-00DF7EDE39ADQ35231568-733045AE-2FCC-4EFC-8881-F90A2873B786Q35930606-366DE426-3BF8-40CE-88DD-E5186AE66344Q36285092-951FD930-FF22-4343-AA54-5D2DBDDBC974Q37021514-0EFFCB81-AAEE-4045-B27D-79A90F9C4181Q37207116-6AB11991-43C1-49E8-A83C-E4BD0548128FQ37376779-E704EE5F-3F64-4125-94D6-020F8A6D56A7Q37518390-2DF5C0EF-77FB-4ECA-8F3E-0FB2352CB3F5Q39011868-6FEFDB13-4C52-4ACC-B0C7-E658C8EC3D22Q40269112-4A3BEF5C-B0C2-4BC1-9EFC-1ED1BF3C2838Q40561879-DA51F94F-AFF5-4E32-B1E2-93A4DD091F08Q40921653-9A329850-655E-4DC4-BD36-D0C0A2E1C910Q40929078-6632508F-8A92-41AC-AD75-E313D6B4B829Q41438010-42706927-FD64-4733-B5C3-C0094FB4566E
P2860
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@en
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@nl
type
label
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@en
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@nl
prefLabel
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@en
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@nl
P2093
P2860
P1476
Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
@en
P2093
A Brett Hauber
A F Mohamed
J Mauskopf
J Medjedovic
P2860
P304
P356
10.1111/J.1365-2893.2010.01343.X
P577
2010-06-22T00:00:00Z